iShares国际国家轮换主动型ETF CORO 深 沪
等待开盘 04-02 09:30:00 美东时间
32.70
+0.547
+1.70%
华盛通- 最 高33.36
- 今 开33.36
- 成交量 232.74万股
- 最 低 32.47
- 昨 收 32.153
- 总市值 30.65亿
- 52周最高 36.5499
- 市盈率 静 --
- 换手率 2.48%
- 52周最低 23.6911
- 委 比 -43.88%
- 总股本 9372.00万
- 历史最高 36.5499
- 量 比 2.98
- 振 幅 2.77%
- 历史最低 21.5447
- 每 手 1
- 风险率 2.88%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多iShares International Country Rotation Active ET declares $0.4891 dividend
iShares International Country Rotation Active ET (CORO) declares $0.4891/share semi-annual dividend. Payable Dec. 29; for shareholders of record Dec. 23; ex-div Dec. 23. See CORO Dividend Scorecard, Y...
2025-12-23 18:24
BRIEF-Philips To Buy SpectraWAVE To Advance AI-enabled Coronary Intravascular Imaging
Dec 15 (Reuters) - Koninklijke Philips NV PHG.AS: PHILIPS AGREES TO ACQUIRE SPECTRAWAVE INC., ADVANCING NEXT-GENERATION CORONARY INTRAVASCULAR IMAGING AND PHYSIOLOGICAL ASSESSMENT WITH AI ACQUISITION ...
2025-12-15 15:04
BRIEF-SK Bioscience Files For First-In-Human Trial Of Universal Coronavirus Vaccine GBP511 Phase 1/2 Study In Australia
Oct 15 (Reuters) - SK Bioscience Co Ltd 302440.KS: SK BIOSCIENCE FILES FOR FIRST-IN-HUMAN TRIAL OF UNIVERSAL CORONAVIRUS VACCINE (PAN-SARBECOVIRUS VACCINE) GBP511 PHASE 1/2 STUDY IN AUSTRALIA SK BIOSC...
2025-10-15 20:03
BRIEF-Liberty Latin America Announces Retirement Of Eduardo Diaz Corona, SVP And General Manager Of Liberty Puerto Rico And Usvi
July 15 (Reuters) - Liberty Latin America Ltd LILA.O: LIBERTY LATIN AMERICA ANNOUNCES RETIREMENT OF EDUARDO DIAZ CORONA, SVP AND GENERAL MANAGER OF LIBERTY PUERTO RICO AND USVI Source text: ID:nBw2438...
2025-07-16 04:49
iShares International Country Rotation Active ET declares $0.2787 dividend
iShares International Country Rotation Active ET (NASDAQ:CORO) declares $0.2787/share semi-annual dividend. Payable July 8; for shareholders of record July 2; ex-div July 2. See CORO Dividend Scorecar...
2025-07-02 19:50
BRIEF-Artrya Ltd Submits FDA 510(K) Application For Salix Coronary Plaque Module
June 16 (Reuters) - Artrya Ltd AYA.AX: SUBMITS FDA 510(K) APPLICATION FOR SALIX CORONARY PLAQUE MODULE Further company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;))
2025-06-16 09:29
BRIEF-Artrya Secures FDA Clearance For Salix Coronary Anatomy
March 28 (Reuters) - Artrya Ltd AYA.AX: SECURES FDA CLEARANCE FOR SALIX CORONARY ANATOMY Further company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;))
2025-03-28 09:14
BRIEF-Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease
March 24 (Reuters) - Abbott Laboratories ABT.N: ABBOTT INITIATES NEW INTRAVASCULAR LITHOTRIPSY CLINICAL TRIAL TO IMPROVE OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE ABBOTT LABORATORIES - TECTONI...
2025-03-24 21:10
BRIEF-Cocrystal Pharma Reports Phase 1 Results With Oral, Broad-Acting Antiviral Drug CDI-988 For Prophylaxis And Treatment Of Norovirus, Coronaviruses And Other Viral Infections
Jan 8 (Reuters) - Cocrystal Pharma Inc COCP.O: COCRYSTAL PHARMA REPORTS PHASE 1 RESULTS WITH ORAL, BROAD-ACTING ANTIVIRAL DRUG CDI-988 FOR PROPHYLAXIS AND TREATMENT OF NOROVIRUS, CORONAVIRUSES AND OTH...
2025-01-08 21:56
